Global Direct-to-consumer Genetic Testing Market 2017-2021
出 版 商：Technavio
出版日期：2017/07/26
頁 數：117頁
文件格式：PDF
價 格：
USD 3,500 (Single-User License)
USD 4,000 (Multi-User License)
USD 5,000 (Global-User License)
USD 4,000 (Multi-User License)
USD 5,000 (Global-User License)
About Direct-to-consumer Genetic Testing
DTC genetic testing is a service that is offered by companies, retail, and clinical diagnostic laboratories directly to the consumer. DTC genetic testing services are marketed to consumers through television and print and online advertisements. DTC genetic testing is widely adopted owing to increasing awareness about gene sequencing for the early detection of diseases. However, in many countries, companies also conduct gene sequencing for matchmaking, to ascertain ancestry, and to check the vitamin level in the body.
Technavio’s analysts forecast the global direct-to-consumer genetic testing market to grow at a CAGR of 11.68% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global direct-to-consumer genetic testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of DTC genetic testing services. It does not include the cost of test kits and shipping charges.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global Direct-to-consumer Genetic Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ 23andMe
‧ LabCorp
‧ Myriad Genetics
‧ Quest Diagnostics
Other prominent vendors
‧ African Ancestry
‧ Alpha Biolaboratories
‧ Ambry Genetics
‧ AncestrybyDNA
‧ Anglia DNA Services
‧ Canadian DNA Services
‧ Centrillion Technology
‧ Color Genomics
‧ Counsyl
‧ Dante Labs
‧ DNA Diagnostics Center
‧ DNA Family Check
‧ DNA4Life
‧ DNA Services of America
‧ EasyDNA
‧ Full Genomes
‧ 24genetics
‧ Gene By Gene
‧ GHC GENETICS
‧ Genetic Health
‧ IDENTIGENE
‧ IntelliGenetics
‧ Invitae
‧ Living DNA
‧ Mapmygenome
‧ MyHeritage
‧ Pathway Genomics
‧ Positive Bioscience
‧ SureGenomics
‧ Shuwen Health Sciences
‧ Sonora Quest Laboratories
‧ Test Me DNA
‧ VCGS
‧ Walk-In Lab
‧ Xcode
Market driver
‧ Chronic disorders in adult population
‧ For a full, detailed list, view our report
Market challenge
‧ Strict guidelines by FDA and FTC in US
‧ For a full, detailed list, view our report
Market trend
‧ Development of online applications to serve customer needs
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2021 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
DTC genetic testing is a service that is offered by companies, retail, and clinical diagnostic laboratories directly to the consumer. DTC genetic testing services are marketed to consumers through television and print and online advertisements. DTC genetic testing is widely adopted owing to increasing awareness about gene sequencing for the early detection of diseases. However, in many countries, companies also conduct gene sequencing for matchmaking, to ascertain ancestry, and to check the vitamin level in the body.
Technavio’s analysts forecast the global direct-to-consumer genetic testing market to grow at a CAGR of 11.68% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global direct-to-consumer genetic testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of DTC genetic testing services. It does not include the cost of test kits and shipping charges.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global Direct-to-consumer Genetic Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ 23andMe
‧ LabCorp
‧ Myriad Genetics
‧ Quest Diagnostics
Other prominent vendors
‧ African Ancestry
‧ Alpha Biolaboratories
‧ Ambry Genetics
‧ AncestrybyDNA
‧ Anglia DNA Services
‧ Canadian DNA Services
‧ Centrillion Technology
‧ Color Genomics
‧ Counsyl
‧ Dante Labs
‧ DNA Diagnostics Center
‧ DNA Family Check
‧ DNA4Life
‧ DNA Services of America
‧ EasyDNA
‧ Full Genomes
‧ 24genetics
‧ Gene By Gene
‧ GHC GENETICS
‧ Genetic Health
‧ IDENTIGENE
‧ IntelliGenetics
‧ Invitae
‧ Living DNA
‧ Mapmygenome
‧ MyHeritage
‧ Pathway Genomics
‧ Positive Bioscience
‧ SureGenomics
‧ Shuwen Health Sciences
‧ Sonora Quest Laboratories
‧ Test Me DNA
‧ VCGS
‧ Walk-In Lab
‧ Xcode
Market driver
‧ Chronic disorders in adult population
‧ For a full, detailed list, view our report
Market challenge
‧ Strict guidelines by FDA and FTC in US
‧ For a full, detailed list, view our report
Market trend
‧ Development of online applications to serve customer needs
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2021 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
‧ Overview
‧ DTC genetic testing
PART 05: Market landscape
‧ Overview
‧ Market size and forecast
‧ Five forces analysis
PART 06: Segmentation by service
‧ Diagnostic screening
‧ Prenatal, newborn screening, and pre-implantation diagnosis
‧ Relationship testing
PART 07: Segmentation by channel
‧ Overview
‧ Direct sales
‧ Clinical laboratories
‧ Retail sales
PART 08: Segmentation by geography
‧ Americas
‧ EMEA
‧ APAC
PART 09: Decision framework
PART 10: Drivers and challenges
‧ Market drivers
‧ Market challenges
PART 11: Market trends
‧ Paradigm shift in business models
‧ Next-generation sequencing and biochip for present and future genetic diagnosis
‧ Development of online applications to serve customer needs
PART 12: Vendor landscape
‧ Competitive landscape
PART 13: Key vendor analysis
‧ 23andMe
‧ LabCorp
‧ Myriad Genetics
‧ Quest Diagnostics
‧ Other prominent vendors
PART 14: Appendix
‧ List of abbreviations
List of Exhibits?
Exhibit 01: DTC genetic testing process
Exhibit 02: Limitations of DTC genetic testing and key focus of companies
Exhibit 03: Global DTC genetic testing market 2016-2021 ($ million)
Exhibit 04: Adoption of DTC genetic testing and average cost of preferred tests
Exhibit 05: Five forces analysis
Exhibit 06: DTC genetic testing services: Adoption
Exhibit 07: Global DTC genetic testing market: Segmentation by service 2016
Exhibit 08: Diagnostic screening using DTC genetic testing: Purpose, companies that offer services, and price
Exhibit 09: Diagnostic screening using DTC genetic testing: Overview
Exhibit 10: Diagnostic screening using DTC genetic testing: Market insights
Exhibit 11: Prenatal, newborn screening, and pre-implantation diagnosis using DTC genetic testing services: Overview
Exhibit 12: Prenatal, newborn screening, and pre-implantation diagnosis: Market insights
Exhibit 13: Relationship testing using DTC genetic testing services: Overview
Exhibit 14: Global DTC genetic testing market: Segmentation by distribution channel 2016 (% share)
Exhibit 15: DTC genetic testing through direct sales: Overview
Exhibit 16: Direct sales: Market impact analysis
Exhibit 17: DTC genetic testing companies and laboratories: Consumer approach
Exhibit 18: Clinical laboratories: Regulatory paradigm analysis
Exhibit 19: Retail sales of paternity tests: Overview
Exhibit 20: Global DTC genetic testing market: Segmentation by geography 2016 and 2021 ($ million)
Exhibit 21: DTC genetic testing market in Americas: Overview
Exhibit 22: DTC genetic testing market in Americas 2016-2021 ($ million)
Exhibit 23: DTC genetic testing market based on countries in Americas: Analysis
Exhibit 24: DTC genetic testing in US: Overview
Exhibit 25: Role of regulatory in genetic tests and services in US
Exhibit 26: DTC genetic testing in US: Market dynamics
Exhibit 27: Legislations related to DTC genetic testing in European countries
Exhibit 28: Hospital admissions for diabetes in EMEA 2008 and 2013 (per 10,000 people)
Exhibit 29: DTC genetic testing in EMEA: Overview
Exhibit 30: DTC genetic testing market in EMEA 2016-2021 ($ million)
Exhibit 31: DTC genetic testing market based on countries in EMEA: Analysis
Exhibit 32: DTC genetic testing in UK: Overview
Exhibit 33: DTC genetic testing in UK: Market dynamics
Exhibit 34: DTC genetic testing in APAC: Overview
Exhibit 35: DTC genetic testing market in APAC 2016-2021 ($ million)
Exhibit 36: DTC genetic testing market based on countries in EMEA: Analysis
Exhibit 37: Growth of aging population aged 55 or more 2010-2050 (%)
Exhibit 38: Sick leaves among people aged between 50 and 59 years in European countries due to chronic diseases 2013 (days)
Exhibit 39: Clinical studies on DTC genetic testing awareness and market impact analysis
Exhibit 40: Partnership models
Exhibit 41: Price difference in hereditary breast cancer testing
Exhibit 42: FDA warning letters to companies
Exhibit 43: Business models of DTC genetic testing companies
Exhibit 44: Applications and insights
Exhibit 45: Competitive structure analysis of global DTC genetic testing market 2016
Exhibit 46: Competitive landscape analysis of global DTC genetic testing market 2016
Exhibit 47: Strategic recommendations for new entrants
Exhibit 48: Key recommendations for companies in the global DTC genetic testing market
Exhibit 49:andMe: Key highlights
Exhibit 50:andMe: Strength assessment
Exhibit 51:andMe: Strategy assessment
Exhibit 52:andMe: Opportunity assessment
Exhibit 53: LabCorp: Key highlights
Exhibit 54: LabCorp: Strength assessment
Exhibit 55: LabCorp: Strategy assessment
Exhibit 56: LabCorp: Opportunity assessment
Exhibit 57: Myriad Genetics: Key highlights
Exhibit 58: Myriad Genetics: Strength assessment
Exhibit 59: Myriad Genetics: Strategy assessment
Exhibit 60: Myriad Genetics: Opportunity assessment
Exhibit 61: Quest Diagnostics: Key highlights
Exhibit 62: Quest Diagnostics: Strength assessment
Exhibit 63: Quest Diagnostics: Strategy assessment
Exhibit 64: Quest Diagnostics: Opportunity assessment
Exhibit 65: Other prominent vendors
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
‧ Overview
‧ DTC genetic testing
PART 05: Market landscape
‧ Overview
‧ Market size and forecast
‧ Five forces analysis
PART 06: Segmentation by service
‧ Diagnostic screening
‧ Prenatal, newborn screening, and pre-implantation diagnosis
‧ Relationship testing
PART 07: Segmentation by channel
‧ Overview
‧ Direct sales
‧ Clinical laboratories
‧ Retail sales
PART 08: Segmentation by geography
‧ Americas
‧ EMEA
‧ APAC
PART 09: Decision framework
PART 10: Drivers and challenges
‧ Market drivers
‧ Market challenges
PART 11: Market trends
‧ Paradigm shift in business models
‧ Next-generation sequencing and biochip for present and future genetic diagnosis
‧ Development of online applications to serve customer needs
PART 12: Vendor landscape
‧ Competitive landscape
PART 13: Key vendor analysis
‧ 23andMe
‧ LabCorp
‧ Myriad Genetics
‧ Quest Diagnostics
‧ Other prominent vendors
PART 14: Appendix
‧ List of abbreviations
List of Exhibits?
Exhibit 01: DTC genetic testing process
Exhibit 02: Limitations of DTC genetic testing and key focus of companies
Exhibit 03: Global DTC genetic testing market 2016-2021 ($ million)
Exhibit 04: Adoption of DTC genetic testing and average cost of preferred tests
Exhibit 05: Five forces analysis
Exhibit 06: DTC genetic testing services: Adoption
Exhibit 07: Global DTC genetic testing market: Segmentation by service 2016
Exhibit 08: Diagnostic screening using DTC genetic testing: Purpose, companies that offer services, and price
Exhibit 09: Diagnostic screening using DTC genetic testing: Overview
Exhibit 10: Diagnostic screening using DTC genetic testing: Market insights
Exhibit 11: Prenatal, newborn screening, and pre-implantation diagnosis using DTC genetic testing services: Overview
Exhibit 12: Prenatal, newborn screening, and pre-implantation diagnosis: Market insights
Exhibit 13: Relationship testing using DTC genetic testing services: Overview
Exhibit 14: Global DTC genetic testing market: Segmentation by distribution channel 2016 (% share)
Exhibit 15: DTC genetic testing through direct sales: Overview
Exhibit 16: Direct sales: Market impact analysis
Exhibit 17: DTC genetic testing companies and laboratories: Consumer approach
Exhibit 18: Clinical laboratories: Regulatory paradigm analysis
Exhibit 19: Retail sales of paternity tests: Overview
Exhibit 20: Global DTC genetic testing market: Segmentation by geography 2016 and 2021 ($ million)
Exhibit 21: DTC genetic testing market in Americas: Overview
Exhibit 22: DTC genetic testing market in Americas 2016-2021 ($ million)
Exhibit 23: DTC genetic testing market based on countries in Americas: Analysis
Exhibit 24: DTC genetic testing in US: Overview
Exhibit 25: Role of regulatory in genetic tests and services in US
Exhibit 26: DTC genetic testing in US: Market dynamics
Exhibit 27: Legislations related to DTC genetic testing in European countries
Exhibit 28: Hospital admissions for diabetes in EMEA 2008 and 2013 (per 10,000 people)
Exhibit 29: DTC genetic testing in EMEA: Overview
Exhibit 30: DTC genetic testing market in EMEA 2016-2021 ($ million)
Exhibit 31: DTC genetic testing market based on countries in EMEA: Analysis
Exhibit 32: DTC genetic testing in UK: Overview
Exhibit 33: DTC genetic testing in UK: Market dynamics
Exhibit 34: DTC genetic testing in APAC: Overview
Exhibit 35: DTC genetic testing market in APAC 2016-2021 ($ million)
Exhibit 36: DTC genetic testing market based on countries in EMEA: Analysis
Exhibit 37: Growth of aging population aged 55 or more 2010-2050 (%)
Exhibit 38: Sick leaves among people aged between 50 and 59 years in European countries due to chronic diseases 2013 (days)
Exhibit 39: Clinical studies on DTC genetic testing awareness and market impact analysis
Exhibit 40: Partnership models
Exhibit 41: Price difference in hereditary breast cancer testing
Exhibit 42: FDA warning letters to companies
Exhibit 43: Business models of DTC genetic testing companies
Exhibit 44: Applications and insights
Exhibit 45: Competitive structure analysis of global DTC genetic testing market 2016
Exhibit 46: Competitive landscape analysis of global DTC genetic testing market 2016
Exhibit 47: Strategic recommendations for new entrants
Exhibit 48: Key recommendations for companies in the global DTC genetic testing market
Exhibit 49:andMe: Key highlights
Exhibit 50:andMe: Strength assessment
Exhibit 51:andMe: Strategy assessment
Exhibit 52:andMe: Opportunity assessment
Exhibit 53: LabCorp: Key highlights
Exhibit 54: LabCorp: Strength assessment
Exhibit 55: LabCorp: Strategy assessment
Exhibit 56: LabCorp: Opportunity assessment
Exhibit 57: Myriad Genetics: Key highlights
Exhibit 58: Myriad Genetics: Strength assessment
Exhibit 59: Myriad Genetics: Strategy assessment
Exhibit 60: Myriad Genetics: Opportunity assessment
Exhibit 61: Quest Diagnostics: Key highlights
Exhibit 62: Quest Diagnostics: Strength assessment
Exhibit 63: Quest Diagnostics: Strategy assessment
Exhibit 64: Quest Diagnostics: Opportunity assessment
Exhibit 65: Other prominent vendors
